Close
Courage over Cancer Filtered Blog
What lung cancer patients need to know about cardiothoracic surgery
Cardiothoracic surgery is considered the most effective treatment for early-stage lung cancer because it offers the greatest likelihood of a cure.
Read more
Two UT Health San Antonio scientists awarded V Foundation grants to advance innovative cancer research
This year in the United States, it is projected that more than 2 million people will be diagnosed with cancer. Additionally, more than 600,000 people will die of the disease — an average of nearly 1,680 each day. The V Foundation for Cancer Research was founded in 1993 by ESPN and basketball coach Jim Valvano […]
Read moreLife, legacy of 2024 Basser Global Prize winner Patrick Sung
World-renowned biochemist and expert on the roles of BRCA1 and BRCA 2 in DNA repair, Patrick Sung, DPhil, director of the Greehey Children’s Cancer Research Institute and associate dean for research at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was recently recognized as the 2024 recipient of the […]
Read more
Center for Pain Therapeutics and Addiction Research earns first NIH grant
The School of Dentistry earned the first National Institutes of Health grant under its new Center for Pain Therapeutics and Addiction Research, addressing pain in patients with head and neck carcinoma.
Read more
UT Health San Antonio world-renowned expert in BRCA research to be honored for global contributions
Patrick Sung, DPhil, director of the Greehey Children’s Cancer Research Institute and associate dean for research at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is the latest recipient of the 2024 Basser Global Prize. A leading researcher in the field of DNA damage repair and cancer biology, Sung has been awarded the […]
Read more
Palliative or supportive care: What's in a name?
As a hospice and palliative care specialist, I see the dedication of our dietitian as she arranges essential supplies and counsels our patients.
Read more
Mays Cancer Center radiation oncologist recognized as outstanding mentor to next generation leaders
David Gius, MD, PhD, professor in the Department of Radiation Oncology and assistant dean of research at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), was named this year’s recipient of the prestigious American Society for Radiation Oncology (ASTRO) Career Recognition Mentorship Award. David Gius, MD, PhD Gius is associate cancer center director […]
Read more
Game-changing prostate cancer treatment available at UT Health San Antonio
One in eight men will develop prostate cancer in their lifetime. Of those, one in 44 men will die of the disease. Those statistics from the American Cancer Society are startling. But men facing an advanced prostate cancer diagnosis who are seeking additional treatment options now have one more arrow in their quiver to […]
Read more
Oral health’s hidden role in cancer care
Dental care is crucial for cancer patients and survivors to help reduce complications, improve treatment tolerance and enhance overall quality of life, according to oral medicine specialist Tiffany Tavares, DDS, DMSc.
Read more
Henrich, new hospital supporters recognized at Luminary event
The stars aligned perfectly during a night of celebration at the second annual President’s Luminary Honors event at The University of Texas Health Science Center at San Antonio. The annual event, which took place at the soon-to-open UT Health San Antonio Multispecialty and Research Hospital, paid tribute to the legacy of William L. Henrich, […]
Read more
Renowned cancer researcher brings $500,000 UT System Faculty STARs award to UT Health San Antonio
Simon Gayther, PhD, professor of medicine in the Division of Hematology and Oncology in the Joe R. and Teresa Lozano Long School of Medicine and founding director in the school’s Center for Inherited Oncogenesis at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), received a $500,000 UT System […]
Read more
Gene-mutation pathway discovery paves way for targeted blood cancers therapies
Approximately 30% of individuals with myeloid malignancy diseases have a mutation in a certain gene called tet methylcytosine dioxygenase 2 (TET2). This gene is responsible for providing instructions on creating certain proteins and is known to have a tumor-suppressive function. A study published October 2 in Nature is the first to explain the pathway […]
Read more